Perceptive Advisors as of Dec. 31, 2014
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 145 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 10.1 | $120M | 14M | 8.32 | |
Neurocrine Biosciences (NBIX) | 9.7 | $115M | 5.2M | 22.34 | |
Sarepta Therapeutics (SRPT) | 4.0 | $47M | 3.3M | 14.47 | |
Acelrx Pharmaceuticals | 3.7 | $44M | 6.6M | 6.73 | |
Relypsa | 3.2 | $38M | 1.2M | 30.80 | |
Receptos | 3.0 | $36M | 291k | 122.51 | |
Ptc Therapeutics I (PTCT) | 2.9 | $35M | 672k | 51.77 | |
ACADIA Pharmaceuticals (ACAD) | 2.9 | $35M | 1.1M | 31.75 | |
Tesaro | 2.8 | $33M | 883k | 37.19 | |
Xencor (XNCR) | 2.6 | $31M | 1.9M | 16.04 | |
Dyax | 2.2 | $26M | 1.9M | 14.06 | |
Lion Biotechnologies | 2.1 | $25M | 3.2M | 7.87 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $25M | 210k | 118.80 | |
Bellicum Pharma | 2.0 | $24M | 1.0M | 23.04 | |
Retrophin | 2.0 | $24M | 1.9M | 12.24 | |
Taro Pharmaceutical Industries (TARO) | 1.9 | $23M | 154k | 148.19 | |
Bluebird Bio (BLUE) | 1.7 | $21M | 225k | 91.72 | |
Versartis | 1.7 | $20M | 931k | 21.20 | |
Ophthotech | 1.6 | $19M | 429k | 44.87 | |
Biosante Pharmaceuticals (ANIP) | 1.5 | $18M | 313k | 56.39 | |
Allergan | 1.5 | $18M | 83k | 212.59 | |
Zimmer Holdings (ZBH) | 1.5 | $18M | 154k | 113.42 | |
Celgene Corporation | 1.4 | $16M | 147k | 111.86 | |
Thoratec Corporation | 1.3 | $16M | 493k | 32.46 | |
Otonomy | 1.3 | $15M | 454k | 33.33 | |
Neptune Technologies Bioreso | 1.1 | $13M | 6.8M | 1.90 | |
Acceleron Pharma | 1.0 | $12M | 318k | 38.96 | |
Esperion Therapeutics (ESPR) | 1.0 | $12M | 303k | 40.44 | |
Sangamo Biosciences (SGMO) | 1.0 | $12M | 800k | 15.21 | |
Becton, Dickinson and (BDX) | 0.9 | $11M | 80k | 139.16 | |
Insmed (INSM) | 0.9 | $11M | 686k | 15.47 | |
Vanda Pharmaceuticals (VNDA) | 0.8 | $10M | 700k | 14.32 | |
Zafgen | 0.7 | $8.6M | 278k | 30.84 | |
Quotient | 0.7 | $8.2M | 454k | 18.00 | |
Epizyme | 0.7 | $8.2M | 433k | 18.87 | |
Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.7 | $7.9M | 7.5M | 1.05 | |
Macrogenics (MGNX) | 0.6 | $7.6M | 216k | 35.07 | |
BioDelivery Sciences International | 0.6 | $7.3M | 605k | 12.02 | |
Tokai Pharmaceuticals | 0.6 | $7.2M | 485k | 14.74 | |
Coherus Biosciences (CHRS) | 0.6 | $7.1M | 438k | 16.32 | |
Nevro (NVRO) | 0.6 | $6.8M | 177k | 38.67 | |
Heron Therapeutics (HRTX) | 0.6 | $6.7M | 666k | 10.06 | |
Applied Genetic Technol Corp C | 0.5 | $6.3M | 301k | 21.02 | |
Capital Senior Living Corporation | 0.5 | $6.2M | 250k | 24.91 | |
Affimed Therapeutics B V | 0.5 | $6.2M | 1.0M | 6.20 | |
Transenterix | 0.5 | $6.1M | 2.1M | 2.91 | |
Alliqua | 0.5 | $5.9M | 1.1M | 5.30 | |
Cempra | 0.5 | $5.8M | 248k | 23.51 | |
La Jolla Pharmaceuticl Com Par | 0.5 | $5.3M | 289k | 18.45 | |
Prothena (PRTA) | 0.4 | $5.1M | 247k | 20.76 | |
China Biologic Products | 0.4 | $5.0M | 74k | 67.24 | |
Ardelyx (ARDX) | 0.4 | $4.8M | 256k | 18.89 | |
Neuroderm Ltd F | 0.4 | $4.9M | 350k | 14.04 | |
Plasmatech Biopharmaceutical | 0.4 | $4.4M | 1.3M | 3.50 | |
Xenon Pharmaceuticals (XENE) | 0.4 | $4.4M | 225k | 19.75 | |
Mylan | 0.4 | $4.3M | 76k | 56.37 | |
Quidel Corporation | 0.3 | $4.1M | 143k | 28.92 | |
Five Prime Therapeutics | 0.3 | $4.2M | 155k | 27.00 | |
Tetraphase Pharmaceuticals | 0.3 | $4.0M | 100k | 39.71 | |
Actavis | 0.3 | $3.9M | 15k | 257.42 | |
Tenet Healthcare Corporation (THC) | 0.3 | $3.8M | 76k | 50.68 | |
Alere | 0.3 | $3.7M | 98k | 38.00 | |
Flamel Technologies | 0.3 | $3.7M | 644k | 5.71 | |
Hca Holdings (HCA) | 0.3 | $3.6M | 49k | 73.40 | |
Endologix | 0.3 | $3.2M | 210k | 15.29 | |
Dbv Technologies S A | 0.3 | $3.1M | 113k | 27.12 | |
Pfenex | 0.2 | $3.0M | 405k | 7.32 | |
Vascular Biogenics Ltd ord | 0.2 | $3.0M | 500k | 5.91 | |
Keryx Biopharmaceuticals | 0.2 | $2.8M | 200k | 14.15 | |
Derma Sciences | 0.2 | $2.9M | 314k | 9.31 | |
Uniqure Nv (QURE) | 0.2 | $2.9M | 196k | 14.81 | |
Proteon Therapeutics | 0.2 | $2.9M | 275k | 10.40 | |
Arno Therapeutics | 0.2 | $2.7M | 2.0M | 1.35 | |
Dermira | 0.2 | $2.8M | 152k | 18.11 | |
Medgenics | 0.2 | $2.6M | 514k | 5.06 | |
Sage Therapeutics (SAGE) | 0.2 | $2.6M | 71k | 36.60 | |
Juno Therapeutics | 0.2 | $2.6M | 50k | 52.22 | |
Vericel (VCEL) | 0.2 | $2.6M | 850k | 3.04 | |
Smith & Nephew (SNN) | 0.2 | $2.5M | 67k | 36.75 | |
Genvec | 0.2 | $2.2M | 1.0M | 2.14 | |
Shire | 0.2 | $2.1M | 10k | 212.50 | |
Alimera Sciences | 0.2 | $2.1M | 382k | 5.54 | |
Mgc Diagnostics | 0.2 | $2.2M | 336k | 6.40 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $2.2M | 100k | 21.67 | |
Repligen Corporation (RGEN) | 0.2 | $2.0M | 100k | 19.80 | |
Abiomed | 0.2 | $1.9M | 50k | 38.06 | |
Celldex Therapeutics | 0.1 | $1.8M | 100k | 18.25 | |
Uroplasty | 0.1 | $1.6M | 766k | 2.06 | |
Agenus | 0.1 | $1.6M | 403k | 3.97 | |
Walgreen Boots Alliance (WBA) | 0.1 | $1.5M | 20k | 76.19 | |
Syneron Medical Ltd ord | 0.1 | $1.4M | 153k | 9.33 | |
Achillion Pharmaceuticals | 0.1 | $1.3M | 106k | 12.25 | |
pSivida | 0.1 | $1.3M | 315k | 4.11 | |
Sunesis Pharmaceuticals | 0.1 | $1.3M | 500k | 2.55 | |
Acasti Pharma | 0.1 | $1.3M | 2.6M | 0.50 | |
MannKind Corporation | 0.1 | $1.0M | 200k | 5.22 | |
Aquinox Pharmaceuticals | 0.1 | $975k | 130k | 7.50 | |
Plasmatech Biopharmaceutical *w exp 10/24/201 | 0.1 | $1.0M | 1.3M | 0.80 | |
Champions Oncology | 0.1 | $813k | 1.6M | 0.50 | |
Anthera Pharmaceutcls | 0.1 | $795k | 503k | 1.58 | |
Achaogen | 0.1 | $783k | 60k | 13.05 | |
Parnell Pharmaceuticals Holdin (PARNF) | 0.1 | $889k | 214k | 4.15 | |
DURECT Corporation | 0.1 | $717k | 907k | 0.79 | |
HEALTH INSURANCE Common equity Innovations shares | 0.1 | $687k | 96k | 7.16 | |
Portola Pharmaceuticals | 0.1 | $708k | 25k | 28.32 | |
Spectranetics Corporation | 0.1 | $565k | 16k | 34.59 | |
Oncothyreon | 0.1 | $618k | 325k | 1.90 | |
Sientra | 0.1 | $621k | 37k | 16.78 | |
Threshold Pharmaceuticals | 0.0 | $509k | 160k | 3.18 | |
Galmed Pharmaceuticals | 0.0 | $435k | 75k | 5.80 | |
Rite Aid Corporation | 0.0 | $318k | 42k | 7.50 | |
LHC | 0.0 | $302k | 9.7k | 31.17 | |
Galena Biopharma | 0.0 | $302k | 200k | 1.51 | |
C.R. Bard | 0.0 | $228k | 1.4k | 166.79 | |
Universal Health Services (UHS) | 0.0 | $248k | 2.2k | 111.06 | |
PAREXEL International Corporation | 0.0 | $223k | 4.0k | 55.68 | |
Aetna | 0.0 | $230k | 2.6k | 88.94 | |
CIGNA Corporation | 0.0 | $228k | 2.2k | 102.75 | |
PDL BioPharma | 0.0 | $232k | 30k | 7.69 | |
Lannett Company | 0.0 | $188k | 4.4k | 42.81 | |
Health Net | 0.0 | $269k | 5.0k | 53.53 | |
Triple-S Management | 0.0 | $254k | 11k | 23.95 | |
Cyberonics | 0.0 | $248k | 4.5k | 55.68 | |
Centene Corporation (CNC) | 0.0 | $258k | 2.5k | 103.86 | |
Skilled Healthcare | 0.0 | $268k | 31k | 8.56 | |
Cambrex Corporation | 0.0 | $248k | 12k | 21.59 | |
Exactech | 0.0 | $245k | 10k | 23.62 | |
U.S. Physical Therapy (USPH) | 0.0 | $216k | 5.2k | 41.89 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $259k | 15k | 16.90 | |
Merge Healthcare | 0.0 | $293k | 82k | 3.55 | |
Select Medical Holdings Corporation (SEM) | 0.0 | $192k | 13k | 14.37 | |
SciClone Pharmaceuticals | 0.0 | $262k | 30k | 8.75 | |
Nanosphere | 0.0 | $276k | 708k | 0.39 | |
BioSpecifics Technologies | 0.0 | $234k | 6.1k | 38.58 | |
Clovis Oncology | 0.0 | $288k | 5.1k | 56.05 | |
Supernus Pharmaceuticals (SUPN) | 0.0 | $185k | 22k | 8.30 | |
Oxigene | 0.0 | $199k | 124k | 1.61 | |
Surgical Care Affiliates | 0.0 | $259k | 7.7k | 33.63 | |
Transgenomic | 0.0 | $253k | 126k | 2.01 | |
Phibro Animal Health Corporati*on Cmn Class A (PAHC) | 0.0 | $237k | 7.5k | 31.49 | |
Civitas Solutions | 0.0 | $231k | 14k | 17.00 | |
Seattle Genetics | 0.0 | $29k | 900.00 | 32.22 | |
XOMA CORP Common equity shares | 0.0 | $1.0k | 200.00 | 5.00 | |
Ohr Pharmaceutical | 0.0 | $50k | 6.0k | 8.33 | |
Cellular Dynamics Internatio | 0.0 | $1.0k | 164.00 | 6.10 |